GeneReach Biotechnology Financial Health

How is GeneReach Biotechnology's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4171's short term assets (NT$1.3B) exceed its short term liabilities (NT$591.4M).

Long Term Liabilities: 4171's short term assets (NT$1.3B) exceed its long term liabilities (NT$141.2M).


Debt to Equity History and Analysis

Debt Level: 4171 has more cash than its total debt.

Reducing Debt: 4171's debt to equity ratio has reduced from 99.6% to 5.7% over the past 5 years.

Debt Coverage: 4171's debt is well covered by operating cash flow (836.7%).

Interest Coverage: 4171's interest payments on its debt are well covered by EBIT (65.7x coverage).


Balance Sheet


Discover healthy companies